1. Home
  2. KURA vs ORLA Comparison

KURA vs ORLA Comparison

Compare KURA & ORLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KURA
  • ORLA
  • Stock Information
  • Founded
  • KURA 2014
  • ORLA 2007
  • Country
  • KURA United States
  • ORLA Canada
  • Employees
  • KURA N/A
  • ORLA N/A
  • Industry
  • KURA Biotechnology: Biological Products (No Diagnostic Substances)
  • ORLA Precious Metals
  • Sector
  • KURA Health Care
  • ORLA Basic Materials
  • Exchange
  • KURA Nasdaq
  • ORLA Nasdaq
  • Market Cap
  • KURA 1.3B
  • ORLA 1.3B
  • IPO Year
  • KURA N/A
  • ORLA N/A
  • Fundamental
  • Price
  • KURA $15.92
  • ORLA $3.96
  • Analyst Decision
  • KURA Strong Buy
  • ORLA Buy
  • Analyst Count
  • KURA 7
  • ORLA 2
  • Target Price
  • KURA $29.83
  • ORLA $6.13
  • AVG Volume (30 Days)
  • KURA 821.5K
  • ORLA 535.6K
  • Earning Date
  • KURA 11-07-2024
  • ORLA 11-12-2024
  • Dividend Yield
  • KURA N/A
  • ORLA N/A
  • EPS Growth
  • KURA N/A
  • ORLA N/A
  • EPS
  • KURA N/A
  • ORLA 0.01
  • Revenue
  • KURA N/A
  • ORLA $314,101,000.00
  • Revenue This Year
  • KURA N/A
  • ORLA $35.64
  • Revenue Next Year
  • KURA N/A
  • ORLA $0.41
  • P/E Ratio
  • KURA N/A
  • ORLA $284.77
  • Revenue Growth
  • KURA N/A
  • ORLA 38.09
  • 52 Week Low
  • KURA $9.06
  • ORLA $2.60
  • 52 Week High
  • KURA $24.17
  • ORLA $5.17
  • Technical
  • Relative Strength Index (RSI)
  • KURA 34.68
  • ORLA 33.77
  • Support Level
  • KURA $16.55
  • ORLA $3.81
  • Resistance Level
  • KURA $19.73
  • ORLA $4.72
  • Average True Range (ATR)
  • KURA 0.98
  • ORLA 0.20
  • MACD
  • KURA -0.05
  • ORLA -0.13
  • Stochastic Oscillator
  • KURA 8.86
  • ORLA 12.16

About KURA Kura Oncology Inc.

Kura Oncology Inc is a clinical-stage biopharmaceutical company, that engages in discovering and developing therapeutics for the treatment of solid tumors and blood cancers. It focuses on the development of small-molecule product candidates that target cell signaling pathways to drive the progression of various cancers. The company has a product candidate, Tipifarnib, which is a farnesyl transferase inhibitor, in both solid tumors and blood cancers. Geographically operation of the group is carried through the United States.

About ORLA Orla Mining Ltd.

Orla Mining Ltd is a mineral exploration company. It is engaged in the acquisition and exploration of mineral properties. The company holds three gold projects; the Camino Rojo gold and silver project in Zacatecas State, Mexico, and the South Railroad and Lewis gold projects in Nevada, USA, and the Cerro Quema gold project in Panama. It conducts business activities in Mexico, Panama, the United States, and Canada.

Share on Social Networks: